| Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells SL Colombo, M Palacios-Callender, N Frakich, S Carcamo, I Kovacs, ... Proceedings of the National Academy of Sciences 108 (52), 21069-21074, 2011 | 189 | 2011 |
| Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle S Tudzarova, SL Colombo, K Stoeber, S Carcamo, GH Williams, ... Proceedings of the National Academy of Sciences 108 (13), 5278-5283, 2011 | 136 | 2011 |
| SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling T Strub, FG Ghiraldini, S Carcamo, M Li, A Wroblewska, R Singh, ... Nature communications 9 (1), 3440, 2018 | 92 | 2018 |
| Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma S Carcamo, CB Nguyen, E Grossi, D Filipescu, A Alpsoy, A Dhiman, ... Cell reports 39 (1), 2022 | 26 | 2022 |
| A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma RW Zhou, J Xu, TC Martin, AL Zachem, J He, S Ozturk, D Demircioglu, ... Nature Communications 13 (1), 6041, 2022 | 24 | 2022 |
| p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression G Efe, KJ Dunbar, K Sugiura, K Cunningham, S Carcamo, S Karaiskos, ... Cancer Discovery 13 (12), 2632-2651, 2023 | 22 | 2023 |
| MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells D Sun, DK Singh, S Carcamo, D Filipescu, B Khalil, X Huang, BA Miles, ... Science Advances 8 (48), eabo0876, 2022 | 20 | 2022 |
| Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia AG Kotini, S Carcamo, N Cruz-Rodriguez, M Olszewska, T Wang, ... Blood cancer discovery 4 (4), 318-335, 2023 | 18 | 2023 |
| 5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling DK Singh, S Carcamo, EF Farias, D Hasson, W Zheng, D Sun, X Huang, ... Cell reports 42 (6), 2023 | 17 | 2023 |
| MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping D Filipescu, S Carcamo, A Agarwal, N Tung, É Humblin, MS Goldberg, ... Nature Cell Biology 25 (9), 1332-1345, 2023 | 10 | 2023 |
| MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming W Mohammed Ismail, A Mazzone, FG Ghiraldini, J Kaur, M Bains, ... Communications Biology 6 (1), 215, 2023 | 10 | 2023 |
| RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax J Sango, S Carcamo, M Sirenko, A Maiti, H Mansour, G Ulukaya, ... Nature, 1-10, 2024 | 8 | 2024 |
| LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition S Proteau, I Krossa, C Husser, M Guéguinou, F Sella, K Bille, M Irondelle, ... EMBO Molecular Medicine 15 (12), e17719, 2023 | 5 | 2023 |
| Epigenetic reprogramming of DCCs into dormancy suppresses metastasis via restored TGFβ–SMAD4 signaling DK Singh, E Farias, S Carcamo, D Hasson, D Sun, J Cheung, AR Nobre, ... bioRxiv, 2021.08. 01.454684, 2021 | 3 | 2021 |
| H2A. Z chaperones converge on E2F target genes for melanoma cell proliferation S Jostes, C Vardabasso, J Dong, S Carcamo, R Singh, R Phelps, ... Genes & Development 38 (7-8), 336-353, 2024 | 2 | 2024 |
| Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors E Karakose, X Wang, P Wang, S Carcamo, D Demircioglu, L Lambertini, ... Cell Reports Medicine 5 (12), 2024 | 1 | 2024 |
| Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition S Proteau, I Krossa, C Husser, M Guéguinou, F Sella, K Bille, M Irondelle, ... EMBO molecular medicine 16 (9), 2262-2267, 2024 | 1 | 2024 |
| The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin E Grossi, CB Nguyen, S Carcamo, S Moran, VK Callaú, D Filipescu, ... bioRxiv, 2024 | 1 | 2024 |
| N/KRAS-Mutant AML lSCs originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax J Sango, S Carcamo, N Cruz-Rodriguez, M Sirenko, A Maiti, M Olszewska, ... Blood 142, 403, 2023 | 1 | 2023 |
| A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma R Zhou, J Xu, T Martin, A Zachem, J He, S Ozturk, D Demircioglu, ... Cancer Research 83 (7_Supplement), 3481-3481, 2023 | 1 | 2023 |
